The EU AI Act now classifies virtually all AI systems used in hiring, performance management, and workforce planning as 'high-risk,' setting a new global standard for scrutiny. This means companies deploying AI workforce management systems face significant compliance burdens.
Billions flow into AI innovation for workforce and health. Yet, 'high-risk' classifications and mandatory audits simultaneously make deployment complex and costly. This tension creates a critical juncture for the industry.
Companies are trading speed for control and compliance. Those failing to adapt quickly will find their innovative edge blunted by regulatory hurdles.
Global Reach, Local Impact: Who's Under Scrutiny?
- The EU AI Act has extraterritorial effects, potentially covering employers outside Europe if their systems process or influence decisions involving EU-based workers or candidates, according to HR Executive.
- New York City's Local Law 144 requires employers using automated employment decision tools to complete annual independent bias audits and publicly disclose results, according to HR Executive.
These global and local laws mean nearly any company using AI in HR must now consider compliance. New York City's Local Law 144, mandating annual independent bias audits and public disclosure, sets a precedent. This will likely force AI developers to embed ethical design and transparency from the earliest stages, transforming AI development into a socio-legal challenge.
The Billion-Dollar Bet on AI
Assort Health, an AI agents platform, closed a $120 million Series C, bringing its total raised to $222 million and valuing the company at $1.2 billion, according to MarketScale. Cadence, a clinical AI company focused on chronic disease, secured $100 million in a Series C. Stepful, a company that trains healthcare workers, brought in $55 million in a Series C, according to MarketScale.
